WO2008156159A1 - ジアミン誘導体の製造法 - Google Patents

ジアミン誘導体の製造法 Download PDF

Info

Publication number
WO2008156159A1
WO2008156159A1 PCT/JP2008/061296 JP2008061296W WO2008156159A1 WO 2008156159 A1 WO2008156159 A1 WO 2008156159A1 JP 2008061296 W JP2008061296 W JP 2008061296W WO 2008156159 A1 WO2008156159 A1 WO 2008156159A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogen atom
group
ring
production
inhibitors
Prior art date
Application number
PCT/JP2008/061296
Other languages
English (en)
French (fr)
Inventor
Shigeru Noguchi
Takeo Koyama
Original Assignee
Daiichi Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited
Priority to JP2009520545A priority Critical patent/JPWO2008156159A1/ja
Publication of WO2008156159A1 publication Critical patent/WO2008156159A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

活性化血液凝固第Ｘ因子の阻害剤として有用な化合物（１）及び（１ａ）の工業的な製造方法を提供する。 下記の［工程ａ］～［工程ｃ］ ［式中、Ｒ１は水素原子、ハロゲノ基等；Ｒ２は水素原子、ハロゲノ基等；Ｒ３及びＲ４は、同一又は異なって、水素原子又はＣ１～４アルキル基；Ｒ５は、水素原子又はホルミル基；Ｒ６は、水素原子又はメチル基；Ｒ８及びＲ９は、同一又は異なって、メチル基又はエチル基；環Ａはピリジン環等；環Ｂは、４，５，６，７－テトラヒドロチアゾロ［５，４－ｃ］ピリジン環等を示す。］を特徴とする活性化血液凝固第Ｘ因子（ＦＸａ）の阻害剤として有用な化合物（１）及び（１ａ）の工業的な製造方法。
PCT/JP2008/061296 2007-06-21 2008-06-20 ジアミン誘導体の製造法 WO2008156159A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009520545A JPWO2008156159A1 (ja) 2007-06-21 2008-06-20 ジアミン誘導体の製造法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-164176 2007-06-21
JP2007164176 2007-06-21

Publications (1)

Publication Number Publication Date
WO2008156159A1 true WO2008156159A1 (ja) 2008-12-24

Family

ID=40156317

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/061296 WO2008156159A1 (ja) 2007-06-21 2008-06-20 ジアミン誘導体の製造法

Country Status (3)

Country Link
JP (2) JPWO2008156159A1 (ja)
TW (1) TW200909437A (ja)
WO (1) WO2008156159A1 (ja)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010058751A1 (ja) * 2008-11-18 2010-05-27 第一三共株式会社 [１,３,４]オキサジアゾール化合物の薬理上許容される塩又はその水和物
WO2010071121A1 (ja) 2008-12-17 2010-06-24 第一三共株式会社 ジアミン誘導体の製造方法
WO2010082531A1 (ja) 2009-01-13 2010-07-22 第一三共株式会社 活性化血液凝固因子阻害剤
WO2011115066A1 (ja) 2010-03-19 2011-09-22 第一三共株式会社 ジアミン誘導体の結晶およびその製造方法
WO2011115067A1 (ja) 2010-03-19 2011-09-22 第一三共株式会社 抗凝固剤の溶出改善方法
US8258325B2 (en) 2007-02-05 2012-09-04 Evonik Oxeno Gmbh Mixture of diesters of dianhydrohexitol derivatives with carboxylic acids of the empirical formula C8H17COOH, process for preparing these diesters, and use of these mixtures
US8357808B2 (en) 2009-03-10 2013-01-22 Daiichi Sankyo Company, Limited Process for producing diamine derivative
US8449896B2 (en) 2009-06-18 2013-05-28 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved solubility
US8901345B2 (en) 2010-07-02 2014-12-02 Daiichi Sankyo Company, Limited Process for preparation of optically active diamine derivative salt
US9175012B2 (en) 2009-03-13 2015-11-03 Daiichi Sankyo Company, Limited Method for producing optically active diamine derivative
US9402907B2 (en) 2011-08-10 2016-08-02 Daiichi Sankyo Company, Limited Pharmaceutical composition containing diamine derivative
US9707296B2 (en) 2007-03-29 2017-07-18 Daiichi Sankyo Company, Limited Pharmaceutical composition
CN109942600A (zh) * 2019-04-15 2019-06-28 内蒙古京东药业有限公司 一种依度沙班的制备方法
WO2022129535A1 (en) 2020-12-18 2022-06-23 Krka, D.D., Novo Mesto Edoxaban formulation containing no sugar alcohols

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110950886A (zh) * 2019-12-13 2020-04-03 苏州莱克施德药业有限公司 一种合成1-甲基-咪唑-2-甲酸甲酯衍生物的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074774A1 (fr) * 2000-04-05 2001-10-11 Daiichi Pharmaceutical Co., Ltd. Derives ethylenediamine
JP2007070369A (ja) * 2002-12-25 2007-03-22 Dai Ichi Seiyaku Co Ltd ジアミン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11199586A (ja) * 1997-10-23 1999-07-27 Takeda Chem Ind Ltd 縮合型イミダゾピリジン誘導体、その製造法及び剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074774A1 (fr) * 2000-04-05 2001-10-11 Daiichi Pharmaceutical Co., Ltd. Derives ethylenediamine
JP2007070369A (ja) * 2002-12-25 2007-03-22 Dai Ichi Seiyaku Co Ltd ジアミン誘導体

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258325B2 (en) 2007-02-05 2012-09-04 Evonik Oxeno Gmbh Mixture of diesters of dianhydrohexitol derivatives with carboxylic acids of the empirical formula C8H17COOH, process for preparing these diesters, and use of these mixtures
US9707296B2 (en) 2007-03-29 2017-07-18 Daiichi Sankyo Company, Limited Pharmaceutical composition
WO2010058751A1 (ja) * 2008-11-18 2010-05-27 第一三共株式会社 [１,３,４]オキサジアゾール化合物の薬理上許容される塩又はその水和物
WO2010071121A1 (ja) 2008-12-17 2010-06-24 第一三共株式会社 ジアミン誘導体の製造方法
US8404847B2 (en) 2008-12-17 2013-03-26 Daiichi Sankyo Company, Limited Method for producing diamine derivative
US8394821B2 (en) 2009-01-13 2013-03-12 Daiichi Sankyo Company, Limited Activated blood coagulation factor inhibitor
WO2010082531A1 (ja) 2009-01-13 2010-07-22 第一三共株式会社 活性化血液凝固因子阻害剤
US8357808B2 (en) 2009-03-10 2013-01-22 Daiichi Sankyo Company, Limited Process for producing diamine derivative
US9175012B2 (en) 2009-03-13 2015-11-03 Daiichi Sankyo Company, Limited Method for producing optically active diamine derivative
US8449896B2 (en) 2009-06-18 2013-05-28 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved solubility
KR20130016225A (ko) 2010-03-19 2013-02-14 다이이찌 산쿄 가부시키가이샤 디아민 유도체의 결정 및 그 제조 방법
US9918975B2 (en) 2010-03-19 2018-03-20 Daiichi Sankyo Company, Limited Method for improving dissolution of anticoagulant agent
WO2011115066A1 (ja) 2010-03-19 2011-09-22 第一三共株式会社 ジアミン誘導体の結晶およびその製造方法
US8541443B2 (en) 2010-03-19 2013-09-24 Daiichi Sankyo Company, Limited Crystal of diamine derivative and method of producing same
WO2011115067A1 (ja) 2010-03-19 2011-09-22 第一三共株式会社 抗凝固剤の溶出改善方法
US8901345B2 (en) 2010-07-02 2014-12-02 Daiichi Sankyo Company, Limited Process for preparation of optically active diamine derivative salt
US9402907B2 (en) 2011-08-10 2016-08-02 Daiichi Sankyo Company, Limited Pharmaceutical composition containing diamine derivative
CN109942600A (zh) * 2019-04-15 2019-06-28 内蒙古京东药业有限公司 一种依度沙班的制备方法
CN109942600B (zh) * 2019-04-15 2021-08-20 内蒙古京东药业有限公司 一种依度沙班的制备方法
WO2022129535A1 (en) 2020-12-18 2022-06-23 Krka, D.D., Novo Mesto Edoxaban formulation containing no sugar alcohols

Also Published As

Publication number Publication date
TW200909437A (en) 2009-03-01
JPWO2008156159A1 (ja) 2010-08-26
JP2014051492A (ja) 2014-03-20

Similar Documents

Publication Publication Date Title
WO2008156159A1 (ja) ジアミン誘導体の製造法
SG179207A1 (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
MX2013013857A (es) Compuestos insecticidas.
WO2008071918A8 (en) Pyrido-pyrazine derivatives useful as herbicidal compounds
GB0415746D0 (en) Organic compounds
MX2010005109A (es) Compuestos herbicidas.
TN2009000011A1 (en) Pyrido [2,3-b] pyrazine derivatives useful as herbicidal compounds
MX2007006549A (es) Procedimiento para preparar derivados condensados de piperazin-2-ona, asi como productos intermedios del procedimiento.
WO2008114817A1 (ja) 新規なアデニン化合物
DE602005014473D1 (en) Amino-propanolderivate
WO2014108919A3 (en) NOVEL INTERMEDIATE AND POLYMORPHS OF 1-(4-METHOXYPHENYL)-7-OXO-6-[4-(2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-c] PYRIDINE-3-CARBOXAMIDE AND PROCESS THEREOF
MX2009008781A (es) Derivados de ciclohexano espirociclicos.
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
WO2008130312A8 (en) A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
MY156425A (en) Spirocyclic nitriles as protease inhibitors
WO2007006533A3 (en) Indolylmaleimide derivatives
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
EA200970455A1 (ru) ЗАМЕЩЕННЫЙ 8-ПИПЕРИДИНИЛ-2-ПИРИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОН И ПРОИЗВОДНЫЕ 8-ПИПЕРИДИНИЛ-2-ПИРИМИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОНА
EP1975157A4 (en) PROCESS FOR PRODUCING HETEROAROMATIC CYCLIC COMPOUND HAVING AN N-Rf GROUP
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
MX2015006062A (es) Compuestos de pirazolo [3,4-d] pirimidina sustituidos, su preparacion y su uso como ligandos de sigma.
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
WO2006122020A3 (en) Process for production of 4-biphenylyazetidin-2-ones
MXPA05014191A (es) Procedimiento para preparar derivado de acido 3-acilaminobenzofuran-2-carboxilico.
WO2008093700A1 (ja) トレハロース化合物、その製造方法、及び該化合物を含有する免疫賦活剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08777440

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009520545

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08777440

Country of ref document: EP

Kind code of ref document: A1